nodes	percent_of_prediction	percent_of_DWPC	metapath
Beclomethasone—Nasal irritation—Fluorouracil—urinary bladder cancer	0.0631	0.0779	CcSEcCtD
Beclomethasone—Growth retardation—Thiotepa—urinary bladder cancer	0.0583	0.0719	CcSEcCtD
Beclomethasone—Ageusia—Valrubicin—urinary bladder cancer	0.0472	0.0582	CcSEcCtD
Beclomethasone—Nasal discomfort—Fluorouracil—urinary bladder cancer	0.0383	0.0473	CcSEcCtD
Beclomethasone—Ulcer—Mitomycin—urinary bladder cancer	0.0278	0.0343	CcSEcCtD
Beclomethasone—NR3C1—urine—urinary bladder cancer	0.0229	0.202	CbGeAlD
Beclomethasone—Back pain—Valrubicin—urinary bladder cancer	0.0162	0.0199	CcSEcCtD
Beclomethasone—Cataract—Thiotepa—urinary bladder cancer	0.0139	0.0172	CcSEcCtD
Beclomethasone—Ageusia—Cisplatin—urinary bladder cancer	0.0128	0.0158	CcSEcCtD
Beclomethasone—Rhinorrhoea—Cisplatin—urinary bladder cancer	0.0128	0.0158	CcSEcCtD
Beclomethasone—SERPINA6—renal system—urinary bladder cancer	0.0128	0.113	CbGeAlD
Beclomethasone—Infection—Carboplatin—urinary bladder cancer	0.0125	0.0155	CcSEcCtD
Beclomethasone—Lacrimation increased—Fluorouracil—urinary bladder cancer	0.0119	0.0147	CcSEcCtD
Beclomethasone—Ulcer—Gemcitabine—urinary bladder cancer	0.0118	0.0145	CcSEcCtD
Beclomethasone—Ulcer—Fluorouracil—urinary bladder cancer	0.0116	0.0143	CcSEcCtD
Beclomethasone—Ulcer—Cisplatin—urinary bladder cancer	0.011	0.0135	CcSEcCtD
Beclomethasone—Pain—Carboplatin—urinary bladder cancer	0.0108	0.0133	CcSEcCtD
Beclomethasone—SERPINA6—female reproductive system—urinary bladder cancer	0.0102	0.0905	CbGeAlD
Beclomethasone—Wheezing—Cisplatin—urinary bladder cancer	0.0101	0.0124	CcSEcCtD
Beclomethasone—Ulcer—Etoposide—urinary bladder cancer	0.0101	0.0124	CcSEcCtD
Beclomethasone—Cough—Mitomycin—urinary bladder cancer	0.01	0.0124	CcSEcCtD
Beclomethasone—Dizziness—Valrubicin—urinary bladder cancer	0.00901	0.0111	CcSEcCtD
Beclomethasone—Rash—Valrubicin—urinary bladder cancer	0.00859	0.0106	CcSEcCtD
Beclomethasone—Dermatitis—Valrubicin—urinary bladder cancer	0.00859	0.0106	CcSEcCtD
Beclomethasone—Headache—Valrubicin—urinary bladder cancer	0.00854	0.0105	CcSEcCtD
Beclomethasone—CYP3A5—prostate gland—urinary bladder cancer	0.00828	0.0731	CbGeAlD
Beclomethasone—Nasal congestion—Cisplatin—urinary bladder cancer	0.00827	0.0102	CcSEcCtD
Beclomethasone—NR3C1—prostate gland—urinary bladder cancer	0.00822	0.0726	CbGeAlD
Beclomethasone—Nausea—Valrubicin—urinary bladder cancer	0.0081	0.00999	CcSEcCtD
Beclomethasone—Pain—Mitomycin—urinary bladder cancer	0.00803	0.00991	CcSEcCtD
Beclomethasone—Nasopharyngitis—Fluorouracil—urinary bladder cancer	0.00711	0.00877	CcSEcCtD
Beclomethasone—Epistaxis—Thiotepa—urinary bladder cancer	0.00698	0.00862	CcSEcCtD
Beclomethasone—NR3C1—seminal vesicle—urinary bladder cancer	0.00695	0.0614	CbGeAlD
Beclomethasone—Bronchospasm—Gemcitabine—urinary bladder cancer	0.00687	0.00848	CcSEcCtD
Beclomethasone—Nasopharyngitis—Cisplatin—urinary bladder cancer	0.00674	0.00831	CcSEcCtD
Beclomethasone—Ageusia—Epirubicin—urinary bladder cancer	0.00658	0.00812	CcSEcCtD
Beclomethasone—Dysphonia—Epirubicin—urinary bladder cancer	0.00648	0.00799	CcSEcCtD
Beclomethasone—Dizziness—Mitomycin—urinary bladder cancer	0.00621	0.00766	CcSEcCtD
Beclomethasone—Ageusia—Doxorubicin—urinary bladder cancer	0.00609	0.00751	CcSEcCtD
Beclomethasone—NR3C1—epithelium—urinary bladder cancer	0.00604	0.0533	CbGeAlD
Beclomethasone—Ulcer—Methotrexate—urinary bladder cancer	0.00602	0.00743	CcSEcCtD
Beclomethasone—Dysphonia—Doxorubicin—urinary bladder cancer	0.00599	0.0074	CcSEcCtD
Beclomethasone—Rash—Mitomycin—urinary bladder cancer	0.00592	0.00731	CcSEcCtD
Beclomethasone—Dermatitis—Mitomycin—urinary bladder cancer	0.00591	0.0073	CcSEcCtD
Beclomethasone—Headache—Mitomycin—urinary bladder cancer	0.00588	0.00726	CcSEcCtD
Beclomethasone—Bronchospasm—Etoposide—urinary bladder cancer	0.00587	0.00724	CcSEcCtD
Beclomethasone—NR3C1—smooth muscle tissue—urinary bladder cancer	0.00582	0.0514	CbGeAlD
Beclomethasone—Lacrimation increased—Epirubicin—urinary bladder cancer	0.00578	0.00714	CcSEcCtD
Beclomethasone—Epistaxis—Fluorouracil—urinary bladder cancer	0.00578	0.00713	CcSEcCtD
Beclomethasone—Sinusitis—Fluorouracil—urinary bladder cancer	0.00574	0.00709	CcSEcCtD
Beclomethasone—CYP3A5—renal system—urinary bladder cancer	0.00565	0.0499	CbGeAlD
Beclomethasone—Ulcer—Epirubicin—urinary bladder cancer	0.00563	0.00695	CcSEcCtD
Beclomethasone—NR3C1—renal system—urinary bladder cancer	0.0056	0.0495	CbGeAlD
Beclomethasone—Back pain—Thiotepa—urinary bladder cancer	0.0056	0.00691	CcSEcCtD
Beclomethasone—Nausea—Mitomycin—urinary bladder cancer	0.00558	0.00688	CcSEcCtD
Beclomethasone—Pharyngitis—Gemcitabine—urinary bladder cancer	0.00555	0.00685	CcSEcCtD
Beclomethasone—NR3C1—urethra—urinary bladder cancer	0.0055	0.0486	CbGeAlD
Beclomethasone—Pharyngitis—Fluorouracil—urinary bladder cancer	0.00546	0.00673	CcSEcCtD
Beclomethasone—Lacrimation increased—Doxorubicin—urinary bladder cancer	0.00535	0.0066	CcSEcCtD
Beclomethasone—NR3C1—Endoderm Differentiation—BPTF—urinary bladder cancer	0.00523	0.0684	CbGpPWpGaD
Beclomethasone—Ulcer—Doxorubicin—urinary bladder cancer	0.00521	0.00643	CcSEcCtD
Beclomethasone—Cough—Thiotepa—urinary bladder cancer	0.00505	0.00623	CcSEcCtD
Beclomethasone—CYP3A5—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	0.005	0.0655	CbGpPWpGaD
Beclomethasone—Back pain—Gemcitabine—urinary bladder cancer	0.00471	0.00581	CcSEcCtD
Beclomethasone—Infection—Thiotepa—urinary bladder cancer	0.00469	0.00579	CcSEcCtD
Beclomethasone—NR3C1—female reproductive system—urinary bladder cancer	0.00449	0.0396	CbGeAlD
Beclomethasone—Cough—Gemcitabine—urinary bladder cancer	0.00425	0.00524	CcSEcCtD
Beclomethasone—CYP3A5—vagina—urinary bladder cancer	0.00409	0.0361	CbGeAlD
Beclomethasone—CYP3A5—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.00406	0.0531	CbGpPWpGaD
Beclomethasone—NR3C1—vagina—urinary bladder cancer	0.00406	0.0358	CbGeAlD
Beclomethasone—Pain—Thiotepa—urinary bladder cancer	0.00404	0.00498	CcSEcCtD
Beclomethasone—Back pain—Etoposide—urinary bladder cancer	0.00402	0.00496	CcSEcCtD
Beclomethasone—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.00397	0.0049	CcSEcCtD
Beclomethasone—Infection—Gemcitabine—urinary bladder cancer	0.00395	0.00487	CcSEcCtD
Beclomethasone—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.00391	0.00482	CcSEcCtD
Beclomethasone—Infection—Fluorouracil—urinary bladder cancer	0.00388	0.00479	CcSEcCtD
Beclomethasone—Urticaria—Thiotepa—urinary bladder cancer	0.00375	0.00463	CcSEcCtD
Beclomethasone—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.0037	0.00457	CcSEcCtD
Beclomethasone—Infection—Cisplatin—urinary bladder cancer	0.00368	0.00454	CcSEcCtD
Beclomethasone—Cough—Etoposide—urinary bladder cancer	0.00363	0.00447	CcSEcCtD
Beclomethasone—Nasopharyngitis—Epirubicin—urinary bladder cancer	0.00346	0.00427	CcSEcCtD
Beclomethasone—NR3C1—Signaling events mediated by HDAC Class II—HDAC4—urinary bladder cancer	0.00346	0.0453	CbGpPWpGaD
Beclomethasone—Pain—Gemcitabine—urinary bladder cancer	0.0034	0.00419	CcSEcCtD
Beclomethasone—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00339	0.00419	CcSEcCtD
Beclomethasone—Infection—Etoposide—urinary bladder cancer	0.00337	0.00416	CcSEcCtD
Beclomethasone—Pain—Fluorouracil—urinary bladder cancer	0.00334	0.00412	CcSEcCtD
Beclomethasone—Nasopharyngitis—Doxorubicin—urinary bladder cancer	0.0032	0.00395	CcSEcCtD
Beclomethasone—Pain—Cisplatin—urinary bladder cancer	0.00317	0.00391	CcSEcCtD
Beclomethasone—Dizziness—Thiotepa—urinary bladder cancer	0.00312	0.00385	CcSEcCtD
Beclomethasone—Urticaria—Fluorouracil—urinary bladder cancer	0.0031	0.00383	CcSEcCtD
Beclomethasone—Epistaxis—Methotrexate—urinary bladder cancer	0.003	0.00371	CcSEcCtD
Beclomethasone—Rash—Thiotepa—urinary bladder cancer	0.00298	0.00367	CcSEcCtD
Beclomethasone—Dermatitis—Thiotepa—urinary bladder cancer	0.00297	0.00367	CcSEcCtD
Beclomethasone—Headache—Thiotepa—urinary bladder cancer	0.00296	0.00365	CcSEcCtD
Beclomethasone—Pain—Etoposide—urinary bladder cancer	0.0029	0.00358	CcSEcCtD
Beclomethasone—Pharyngitis—Methotrexate—urinary bladder cancer	0.00284	0.0035	CcSEcCtD
Beclomethasone—Epistaxis—Epirubicin—urinary bladder cancer	0.00281	0.00347	CcSEcCtD
Beclomethasone—Nausea—Thiotepa—urinary bladder cancer	0.0028	0.00346	CcSEcCtD
Beclomethasone—Sinusitis—Epirubicin—urinary bladder cancer	0.0028	0.00345	CcSEcCtD
Beclomethasone—Urticaria—Etoposide—urinary bladder cancer	0.00269	0.00332	CcSEcCtD
Beclomethasone—Pharyngitis—Epirubicin—urinary bladder cancer	0.00266	0.00328	CcSEcCtD
Beclomethasone—NR3C1—lymph node—urinary bladder cancer	0.00262	0.0232	CbGeAlD
Beclomethasone—Epistaxis—Doxorubicin—urinary bladder cancer	0.0026	0.00321	CcSEcCtD
Beclomethasone—Sinusitis—Doxorubicin—urinary bladder cancer	0.00259	0.00319	CcSEcCtD
Beclomethasone—Dizziness—Fluorouracil—urinary bladder cancer	0.00258	0.00319	CcSEcCtD
Beclomethasone—Rash—Gemcitabine—urinary bladder cancer	0.0025	0.00309	CcSEcCtD
Beclomethasone—Dermatitis—Gemcitabine—urinary bladder cancer	0.0025	0.00309	CcSEcCtD
Beclomethasone—Headache—Gemcitabine—urinary bladder cancer	0.00249	0.00307	CcSEcCtD
Beclomethasone—Rash—Fluorouracil—urinary bladder cancer	0.00246	0.00304	CcSEcCtD
Beclomethasone—Dermatitis—Fluorouracil—urinary bladder cancer	0.00246	0.00304	CcSEcCtD
Beclomethasone—Pharyngitis—Doxorubicin—urinary bladder cancer	0.00246	0.00303	CcSEcCtD
Beclomethasone—Headache—Fluorouracil—urinary bladder cancer	0.00245	0.00302	CcSEcCtD
Beclomethasone—Back pain—Methotrexate—urinary bladder cancer	0.00241	0.00297	CcSEcCtD
Beclomethasone—NR3C1—Glucocorticoid receptor regulatory network—KRT5—urinary bladder cancer	0.00236	0.0309	CbGpPWpGaD
Beclomethasone—Nausea—Gemcitabine—urinary bladder cancer	0.00236	0.00291	CcSEcCtD
Beclomethasone—Rash—Cisplatin—urinary bladder cancer	0.00233	0.00288	CcSEcCtD
Beclomethasone—Dermatitis—Cisplatin—urinary bladder cancer	0.00233	0.00288	CcSEcCtD
Beclomethasone—Nausea—Fluorouracil—urinary bladder cancer	0.00232	0.00286	CcSEcCtD
Beclomethasone—Back pain—Epirubicin—urinary bladder cancer	0.00225	0.00278	CcSEcCtD
Beclomethasone—Dizziness—Etoposide—urinary bladder cancer	0.00224	0.00277	CcSEcCtD
Beclomethasone—Nausea—Cisplatin—urinary bladder cancer	0.0022	0.00271	CcSEcCtD
Beclomethasone—Cough—Methotrexate—urinary bladder cancer	0.00217	0.00268	CcSEcCtD
Beclomethasone—Rash—Etoposide—urinary bladder cancer	0.00214	0.00264	CcSEcCtD
Beclomethasone—Dermatitis—Etoposide—urinary bladder cancer	0.00214	0.00264	CcSEcCtD
Beclomethasone—Headache—Etoposide—urinary bladder cancer	0.00212	0.00262	CcSEcCtD
Beclomethasone—Back pain—Doxorubicin—urinary bladder cancer	0.00208	0.00257	CcSEcCtD
Beclomethasone—Cough—Epirubicin—urinary bladder cancer	0.00203	0.00251	CcSEcCtD
Beclomethasone—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.00203	0.00251	CcSEcCtD
Beclomethasone—Infection—Methotrexate—urinary bladder cancer	0.00202	0.00249	CcSEcCtD
Beclomethasone—Nausea—Etoposide—urinary bladder cancer	0.00201	0.00249	CcSEcCtD
Beclomethasone—NR3C1—AP-1 transcription factor network—MT2A—urinary bladder cancer	0.00199	0.0261	CbGpPWpGaD
Beclomethasone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.00194	0.0255	CbGpPWpGaD
Beclomethasone—CYP3A5—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.00192	0.0251	CbGpPWpGaD
Beclomethasone—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.0019	0.00235	CcSEcCtD
Beclomethasone—Infection—Epirubicin—urinary bladder cancer	0.00189	0.00233	CcSEcCtD
Beclomethasone—Cough—Doxorubicin—urinary bladder cancer	0.00188	0.00232	CcSEcCtD
Beclomethasone—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.00176	0.00217	CcSEcCtD
Beclomethasone—Infection—Doxorubicin—urinary bladder cancer	0.00175	0.00216	CcSEcCtD
Beclomethasone—Pain—Methotrexate—urinary bladder cancer	0.00174	0.00214	CcSEcCtD
Beclomethasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—TFRC—urinary bladder cancer	0.00169	0.0222	CbGpPWpGaD
Beclomethasone—NR3C1—Nuclear Receptors—ESR2—urinary bladder cancer	0.00168	0.0219	CbGpPWpGaD
Beclomethasone—Pain—Epirubicin—urinary bladder cancer	0.00163	0.00201	CcSEcCtD
Beclomethasone—Urticaria—Methotrexate—urinary bladder cancer	0.00161	0.00199	CcSEcCtD
Beclomethasone—CYP3A5—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.00158	0.0206	CbGpPWpGaD
Beclomethasone—CYP3A5—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.00157	0.0206	CbGpPWpGaD
Beclomethasone—Urticaria—Epirubicin—urinary bladder cancer	0.00151	0.00186	CcSEcCtD
Beclomethasone—Pain—Doxorubicin—urinary bladder cancer	0.0015	0.00186	CcSEcCtD
Beclomethasone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—urinary bladder cancer	0.00144	0.0188	CbGpPWpGaD
Beclomethasone—Urticaria—Doxorubicin—urinary bladder cancer	0.0014	0.00172	CcSEcCtD
Beclomethasone—Dizziness—Methotrexate—urinary bladder cancer	0.00134	0.00166	CcSEcCtD
Beclomethasone—NR3C1—Nuclear Receptor transcription pathway—ESR2—urinary bladder cancer	0.00132	0.0173	CbGpPWpGaD
Beclomethasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOR1—urinary bladder cancer	0.00132	0.0173	CbGpPWpGaD
Beclomethasone—Rash—Methotrexate—urinary bladder cancer	0.00128	0.00158	CcSEcCtD
Beclomethasone—Dermatitis—Methotrexate—urinary bladder cancer	0.00128	0.00158	CcSEcCtD
Beclomethasone—Headache—Methotrexate—urinary bladder cancer	0.00127	0.00157	CcSEcCtD
Beclomethasone—Dizziness—Epirubicin—urinary bladder cancer	0.00126	0.00155	CcSEcCtD
Beclomethasone—Nausea—Methotrexate—urinary bladder cancer	0.00121	0.00149	CcSEcCtD
Beclomethasone—Rash—Epirubicin—urinary bladder cancer	0.0012	0.00148	CcSEcCtD
Beclomethasone—Dermatitis—Epirubicin—urinary bladder cancer	0.0012	0.00148	CcSEcCtD
Beclomethasone—Headache—Epirubicin—urinary bladder cancer	0.00119	0.00147	CcSEcCtD
Beclomethasone—Dizziness—Doxorubicin—urinary bladder cancer	0.00116	0.00144	CcSEcCtD
Beclomethasone—Nausea—Epirubicin—urinary bladder cancer	0.00113	0.00139	CcSEcCtD
Beclomethasone—Rash—Doxorubicin—urinary bladder cancer	0.00111	0.00137	CcSEcCtD
Beclomethasone—Dermatitis—Doxorubicin—urinary bladder cancer	0.00111	0.00137	CcSEcCtD
Beclomethasone—Headache—Doxorubicin—urinary bladder cancer	0.0011	0.00136	CcSEcCtD
Beclomethasone—CYP3A5—Biological oxidations—GSTZ1—urinary bladder cancer	0.00107	0.014	CbGpPWpGaD
Beclomethasone—CYP3A5—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.00106	0.0139	CbGpPWpGaD
Beclomethasone—Nausea—Doxorubicin—urinary bladder cancer	0.00104	0.00129	CcSEcCtD
Beclomethasone—CYP3A5—Biological oxidations—GSTO2—urinary bladder cancer	0.00102	0.0133	CbGpPWpGaD
Beclomethasone—CYP3A5—Biological oxidations—NAT1—urinary bladder cancer	0.00102	0.0133	CbGpPWpGaD
Beclomethasone—NR3C1—Signaling events mediated by HDAC Class II—ESR1—urinary bladder cancer	0.00102	0.0133	CbGpPWpGaD
Beclomethasone—NR3C1—Nuclear Receptors—ESR1—urinary bladder cancer	0.00102	0.0133	CbGpPWpGaD
Beclomethasone—CYP3A5—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.001	0.0131	CbGpPWpGaD
Beclomethasone—NR3C1—Circadian Clock—NCOR1—urinary bladder cancer	0.000962	0.0126	CbGpPWpGaD
Beclomethasone—CYP3A5—Biological oxidations—UGT2B7—urinary bladder cancer	0.00093	0.0122	CbGpPWpGaD
Beclomethasone—NR3C1—Nuclear Receptors—PPARG—urinary bladder cancer	0.000927	0.0121	CbGpPWpGaD
Beclomethasone—CYP3A5—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000917	0.012	CbGpPWpGaD
Beclomethasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—urinary bladder cancer	0.00091	0.0119	CbGpPWpGaD
Beclomethasone—CYP3A5—Biological oxidations—CYP4B1—urinary bladder cancer	0.000838	0.011	CbGpPWpGaD
Beclomethasone—CYP3A5—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000826	0.0108	CbGpPWpGaD
Beclomethasone—NR3C1—Nuclear Receptor transcription pathway—ESR1—urinary bladder cancer	0.000803	0.0105	CbGpPWpGaD
Beclomethasone—NR3C1—Transcription factor regulation in adipogenesis—TNF—urinary bladder cancer	0.000762	0.00998	CbGpPWpGaD
Beclomethasone—NR3C1—Nuclear Receptor transcription pathway—PPARG—urinary bladder cancer	0.000733	0.00959	CbGpPWpGaD
Beclomethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—urinary bladder cancer	0.000706	0.00925	CbGpPWpGaD
Beclomethasone—NR3C1—Regulation of Androgen receptor activity—CREBBP—urinary bladder cancer	0.000683	0.00894	CbGpPWpGaD
Beclomethasone—NR3C1—Circadian Clock—CREBBP—urinary bladder cancer	0.000663	0.00868	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—PLAU—urinary bladder cancer	0.000662	0.00867	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—ESR1—urinary bladder cancer	0.000623	0.00816	CbGpPWpGaD
Beclomethasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—urinary bladder cancer	0.00062	0.00811	CbGpPWpGaD
Beclomethasone—CYP3A5—Biological oxidations—NAT2—urinary bladder cancer	0.000557	0.0073	CbGpPWpGaD
Beclomethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—urinary bladder cancer	0.000557	0.00729	CbGpPWpGaD
Beclomethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—urinary bladder cancer	0.000555	0.00726	CbGpPWpGaD
Beclomethasone—CYP3A5—Metapathway biotransformation—NAT2—urinary bladder cancer	0.00055	0.0072	CbGpPWpGaD
Beclomethasone—NR3C1—SIDS Susceptibility Pathways—ESR2—urinary bladder cancer	0.000541	0.00709	CbGpPWpGaD
Beclomethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—urinary bladder cancer	0.000486	0.00637	CbGpPWpGaD
Beclomethasone—NR3C1—Adipogenesis—NCOR1—urinary bladder cancer	0.000484	0.00633	CbGpPWpGaD
Beclomethasone—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—urinary bladder cancer	0.000481	0.0063	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—CDKN2A—urinary bladder cancer	0.000478	0.00627	CbGpPWpGaD
Beclomethasone—NR3C1—Regulation of Androgen receptor activity—EP300—urinary bladder cancer	0.000465	0.00609	CbGpPWpGaD
Beclomethasone—NR3C1—Regulation of Androgen receptor activity—SRC—urinary bladder cancer	0.000452	0.00592	CbGpPWpGaD
Beclomethasone—NR3C1—Circadian Clock—EP300—urinary bladder cancer	0.000451	0.00591	CbGpPWpGaD
Beclomethasone—CYP3A5—Biological oxidations—HPGDS—urinary bladder cancer	0.000445	0.00583	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—CXCL8—urinary bladder cancer	0.000434	0.00568	CbGpPWpGaD
Beclomethasone—NR3C1—Adipogenesis—FAS—urinary bladder cancer	0.000434	0.00568	CbGpPWpGaD
Beclomethasone—CYP3A5—Biological oxidations—GSTT1—urinary bladder cancer	0.000432	0.00566	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—IL2—urinary bladder cancer	0.000415	0.00543	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—CCND1—urinary bladder cancer	0.000404	0.00529	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—MMP9—urinary bladder cancer	0.000392	0.00514	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—PTEN—urinary bladder cancer	0.00039	0.00511	CbGpPWpGaD
Beclomethasone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—urinary bladder cancer	0.000382	0.00501	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—EP300—urinary bladder cancer	0.000372	0.00487	CbGpPWpGaD
Beclomethasone—NR3C1—Glucocorticoid receptor regulatory network—IL2—urinary bladder cancer	0.000365	0.00478	CbGpPWpGaD
Beclomethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—urinary bladder cancer	0.000348	0.00456	CbGpPWpGaD
Beclomethasone—NR3C1—Adipogenesis—PPARG—urinary bladder cancer	0.000347	0.00454	CbGpPWpGaD
Beclomethasone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—urinary bladder cancer	0.000345	0.00451	CbGpPWpGaD
Beclomethasone—NR3C1—Adipogenesis—RB1—urinary bladder cancer	0.000332	0.00434	CbGpPWpGaD
Beclomethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—urinary bladder cancer	0.000331	0.00434	CbGpPWpGaD
Beclomethasone—NR3C1—Adipogenesis—IGF1—urinary bladder cancer	0.000329	0.00431	CbGpPWpGaD
Beclomethasone—NR3C1—Glucocorticoid receptor regulatory network—EP300—urinary bladder cancer	0.000328	0.00429	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—MYC—urinary bladder cancer	0.000324	0.00425	CbGpPWpGaD
Beclomethasone—CYP3A5—Biological oxidations—GSTP1—urinary bladder cancer	0.0003	0.00392	CbGpPWpGaD
Beclomethasone—CYP3A5—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000295	0.00387	CbGpPWpGaD
Beclomethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—urinary bladder cancer	0.000289	0.00378	CbGpPWpGaD
Beclomethasone—NR3C1—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.000288	0.00377	CbGpPWpGaD
Beclomethasone—CYP3A5—Biological oxidations—GSTM1—urinary bladder cancer	0.000275	0.0036	CbGpPWpGaD
Beclomethasone—CYP3A5—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000271	0.00355	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—TP53—urinary bladder cancer	0.000266	0.00349	CbGpPWpGaD
Beclomethasone—NR3C1—Adipogenesis—CDKN1A—urinary bladder cancer	0.000238	0.00312	CbGpPWpGaD
Beclomethasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—urinary bladder cancer	0.000235	0.00307	CbGpPWpGaD
Beclomethasone—NR3C1—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000229	0.00299	CbGpPWpGaD
Beclomethasone—NR3C1—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.000229	0.00299	CbGpPWpGaD
Beclomethasone—NR3C1—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.000196	0.00257	CbGpPWpGaD
Beclomethasone—NR3C1—Adipogenesis—TNF—urinary bladder cancer	0.000184	0.00241	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—GSTZ1—urinary bladder cancer	0.000183	0.0024	CbGpPWpGaD
Beclomethasone—NR3C1—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000177	0.00231	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—GSTO2—urinary bladder cancer	0.000174	0.00228	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—NAT1—urinary bladder cancer	0.000174	0.00228	CbGpPWpGaD
Beclomethasone—NR3C1—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.000159	0.00208	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—UGT2B7—urinary bladder cancer	0.000159	0.00208	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—CYP4B1—urinary bladder cancer	0.000143	0.00188	CbGpPWpGaD
Beclomethasone—NR3C1—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.000139	0.00182	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	0.000135	0.00177	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	0.000132	0.00173	CbGpPWpGaD
Beclomethasone—NR3C1—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.000127	0.00166	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—SMC1A—urinary bladder cancer	0.000126	0.00165	CbGpPWpGaD
Beclomethasone—NR3C1—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.000122	0.00159	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—ESR2—urinary bladder cancer	0.00011	0.00144	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—TYMP—urinary bladder cancer	0.000105	0.00138	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—NAT2—urinary bladder cancer	9.53e-05	0.00125	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—NCOR1—urinary bladder cancer	8.5e-05	0.00111	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—RRM2—urinary bladder cancer	8.23e-05	0.00108	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—ERCC2—urinary bladder cancer	7.99e-05	0.00105	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—ENO2—urinary bladder cancer	7.62e-05	0.000998	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	7.62e-05	0.000998	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	7.39e-05	0.000968	CbGpPWpGaD
Beclomethasone—NR3C1—Generic Transcription Pathway—MYC—urinary bladder cancer	7.22e-05	0.000945	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—ESR1—urinary bladder cancer	6.68e-05	0.000875	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—NQO1—urinary bladder cancer	6.14e-05	0.000804	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—PPARG—urinary bladder cancer	6.09e-05	0.000798	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—CREBBP—urinary bladder cancer	5.85e-05	0.000766	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	5.12e-05	0.000671	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—TYMS—urinary bladder cancer	4.76e-05	0.000624	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	4.71e-05	0.000616	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	4.71e-05	0.000616	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—GPX1—urinary bladder cancer	4.51e-05	0.00059	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	4.43e-05	0.000579	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	4.16e-05	0.000545	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—MYC—urinary bladder cancer	3.47e-05	0.000455	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—PPARG—urinary bladder cancer	3.37e-05	0.000442	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	3.24e-05	0.000424	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	2.65e-05	0.000347	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—PTEN—urinary bladder cancer	2.31e-05	0.000303	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—EP300—urinary bladder cancer	2.21e-05	0.000289	CbGpPWpGaD
